In this regard, a study reported an increase in sPD-L1 levels several weeks after ICI treatment, especially in the case of NSCLC or genitourinary cancer patients, and highlighted that the main source of sPD-L1 is the peripheral blood neutrophils. The gene discussed is SPDL1; the disease is non-small cell lung carcinoma.